Gagnon C, Li V, Ebeling PR (2008) Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clin Interv Aging 3:635–645

CAS  PubMed  PubMed Central  Google Scholar 

Maricic M (2010) Intravenous zolendronic acid: what are the indications for male osteoporosis? Curr Osteoporos Rep 8:4–9

PubMed  Google Scholar 

Adler RA (2018) Update on osteoporosis in men. Best Pract Res Clin Endocrinol Metab 32:759–772

PubMed  Google Scholar 

Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L, Amin S, Rouleau PA, Khosla S (2008) A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 23:205–214

PubMed  Google Scholar 

Rochira V, Antonio L, Vanderschueren D (2018) EAA clinical guideline on management of bone health in the andrological outpatient clinic. Andrology 6:272–285

CAS  PubMed  Google Scholar 

Gruenwald DA, Matsumoto AM (2003) Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 51:101–115

Google Scholar 

Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G, Mazziotti G, Aversa A, Isidori AM, Pivonello R, Vignozzi L, Mannucci E, Maggi M, Ferlin A (2022) Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest 45:911–926

CAS  PubMed  Google Scholar 

Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R, Vanderschueren D (2002) Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone. J Bone Miner Res 17:2080–2086

CAS  PubMed  Google Scholar 

Jardí F, Laurent MR, Claessens F, Vanderschueren D (2018) Estradiol and age-related bone loss in men. Physiol Rev 98:1

PubMed  Google Scholar 

Dobs AS, Nguyen T, Pace C, Roberts CP (2002) Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 87:1509–1516

CAS  PubMed  Google Scholar 

Glazier MG, Bowman MA (2001) A review of the evidence for use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 161:1161–1172

CAS  PubMed  Google Scholar 

Narayanan R, Coss CC, Dalton JT (2018) Development of selective androgen receptor modulators (SARMs). Mol Cell Endocrinol 465:134–142

CAS  PubMed  Google Scholar 

Christiansen AR, Lipshultz LI, Hotaling JM, Pastuszak AW (2020) Selective androgen receptor modulators: the future of androgen therapy? Transl Androl Urol 9:S135–S148

PubMed  PubMed Central  Google Scholar 

Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT (2007) Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res 24:328–335

CAS  PubMed  Google Scholar 

Komrakova M, Nagel J, Hoffmann DB, Lehmann W, Schilling AF, Sehmisch S (2020) Effect of selective androgen receptor modulator enobosarm on bone healing in a rat model for aged male osteoporosis. Calcif Tissue Int 107:593–602

CAS  PubMed  PubMed Central  Google Scholar 

Doran PM, Riggs BL, Atkinson EJ, Khosla S (2001) Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res 16:2118–2125

CAS  PubMed  Google Scholar 

Smith MR, Fallon MA, Lee H, Finkelstein JS (2004) Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 89:3841–3846

CAS  PubMed  Google Scholar 

Suermer EK, Sehmisch S, Tezval M, Tezval H, Rack T, Boekhoff J, Wuttke W, Herrmann TR, Seidlova-Wuttke D, Stuermer KM (2009) Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats. World J Urol 27:547–555

Google Scholar 

Roch PJ, Wolgast V, Gebhardt MM, Böker KO, Hoffmann DB, Saul D, Schilling AF, Sehmisch S, Komrakova M (2022) Combination of selective androgen and estrogen receptor modulators in orchiectomized rats. J Endocrinol Investig. https://doi.org/10.1007/s40618-022-01794-7

Article  Google Scholar 

Furuya K, Yamamoto N, Ohyabu Y, Makino A, Morikyu T, Ishige H, Kuzutani K, Endo Y (2012) The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats. Biol Pharm Bull 35:1096–1104

CAS  PubMed  Google Scholar 

Albers J, Markus MA, Alves F, Dullin C (2018) X-ray based virtual histology allows guided sectioning of heavy ion stained murine lungs for histological analysis. Sci Rep 8:7712

PubMed  PubMed Central  Google Scholar 

Saul D, Hohl FE, Franz MK, Meyer I, Taudien S, Roch PJ, Sehmisch S, Komrakova M (2021) Inhibition of lipoxygenases showed no benefit for the musculoskeletal system in estrogen deficient rats. Front Endocrinol. https://doi.org/10.3389/fendo.2021.706504

Article  Google Scholar 

Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using microcomputed tomography. J Bone Miner Res 25:1468–1486

PubMed  Google Scholar 

Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 2:595–610

CAS  PubMed  Google Scholar 

Tezval M, Stuermer EK, Sehmisch S, Rack T, Stary A, Stebener M, Konietschke F, Stuermer KM (2010) Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur. Osteoporos Int 21:251–261

CAS  PubMed  Google Scholar 

Sehmisch S, Erren M, Rack T, Tezval M, Seidlova-Wuttke D, Richter J, Wuttke W, Stuermer KM, Stuermer EK (2009) Short-term effects of parathyroid hormone on rat lumbar vertebrae. Spine (Phila Pa 1976) 34:2014–2021

Google Scholar 

Komrakova M, Stuermer EK, Tezval M, Stuermer KM, Dullin C, Schmelz U, Doell C, Durkaya-Burchhard N, Fuerst B, Genotte T, Sehmisch S (2017) Evaluation of twelve vibration regimes applied to improve spine properties in ovariectomized rats. Bone Rep 7:172–180

Google Scholar 

CEN (2002) European committee for standardization. Determination of calcium and magnesium. EN ISO 7980.

CEN (2004) European committee for standardization. Determination of orthophosphate. EN ISO 6878.

Yorgan TA, Sari H, Rolvien T, Windhorst S, Failla AV, Kornak U, Oheim R, Amling M, Schinke T (2020) Mice lacking plastin-3 display a specific defect of cortical bone acquisition. Bone 130:115062

CAS  PubMed  Google Scholar 

Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17

PubMed  Google Scholar 

Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS (2015) Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. https://doi.org/10.1155/2015/421746

Article  PubMed  PubMed Central  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402–408

CAS  PubMed  Google Scholar 

Komrakova M, Weidemann A, Dullin C, Ebert J, Tezval M, Stuermer KM, Sehmisch S (2015) The impact of strontium ranelate on metaphyseal bone healing in ovariectomized rats. Calcif Tissue Int 97:391–401

CAS  PubMed  Google Scholar 

Takakura A, Takao-Kawabata R, Isogai Y, Kajiwara M, Murayama H, Ejiri S, Ishizuya T (2016) Differences in vertebral, tibial, and iliac cancellous bone metabolism in ovariectomized rats. J Bone Miner Metab 34:291–302

CAS  PubMed  Google Scholar 

Li J, Bao Q, Chen S, Liu H, Feng J, Qin H, Li A, Liu D, Shen Y, Zhao Y, Zong Z (2017) Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice. J Orthop Res 35:812–819

PubMed  Google Scholar 

Gennari L, Merlotti D, De Paola V, Calabrò A, Becherini L, Martini G, Nuti R (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 161:307–320

CAS  PubMed  Google Scholar 

Khalid AB, Krum SA (2016) Estrogen receptors alpha and beta in bone. Bone 87:130–135

CAS  PubMed  PubMed Central  Google Scholar 

Castiglioni S, Cazzaniga A, Albisetti W, Maier JA (2013) Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients 5(3022–303):3

Google Scholar 

Migliaccio S, Brama M, Spera G (2007) The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis. Clin Interv Aging 2:55–64

CAS  PubMed  PubMed Central  Google Scholar 

McAbee MD, DonCarlos LL (1999) Estrogen, but not androgens, regulates androgen receptor messenger ribonucleic acid expression in the developing male rat forebrain. Endocrinology 140:3674–3681

CAS  PubMed  Google Scholar 

Li J-P, Liu P, Gao X-G, Shi Y-P (2021) Effects of raloxifene on fracture healing and OPG/RANKL/RANK system in rats with osteoporotic jaw fracture. China J Oral Maxillofac Surg 19:213–216

Google Scholar 

Chen J-F, Lin P-W, Tsai Y-R, Yang Y-C, Kang H-Y (2019) Androgens and androgen receptor actions on bone health and disease: from androgen deficiency to androgen therapy. Cells 8:1318

CAS  PubMed Central  Google Scholar 

Leder BZ (2018) Optimizing sequential and combined anabolic and antiresorptive osteoporosis therapy. J Bone Miner Res Plus 2:62–68

Google Scholar 

Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH (2005) Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial. J Bone Miner Res 20:1905–1911

CAS  PubMed  Google Scholar 

Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, Lee H, Neer RM (2014) Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial. J Clin Endocrinol Metab 99:1694–1700

CAS